Intellia Therapeutics Inc (NASDAQ:NTLA)

Delayed Data
As of Oct 15
 -1.28 / -0.97%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 174.00, with a high estimate of 250.00 and a low estimate of 130.00. The median estimate represents a +33.24% increase from the last price of 130.59.

Analyst Recommendations

The current consensus among 18 polled investment analysts is to Buy stock in Intellia Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 16.13%
Growthannually -38.36%


Growthquarterly 32.24%
Growthannually -45.40%
Key to the earnings and sales forecast charts.